Cargando…
Comparison of value of biomarkers in diagnosing lung cancer: An overview of systematic reviews protocol
BACKGROUND: In both sexes combined, lung cancer is the most commonly diagnosed cancer and the leading cause of cancer death. Furthermore, the incidence rate is increasing in many countries. Many lung cancer patients have a poor prognosis because they are usually diagnosed at an advanced stage. There...
Autores principales: | Wu, Fanqi, Wang, Hong, Tao, Hongyan, Huang, Huirong, Zhang, Longguo, Wu, Di, Wan, Yixin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531075/ https://www.ncbi.nlm.nih.gov/pubmed/31083197 http://dx.doi.org/10.1097/MD.0000000000015525 |
Ejemplares similares
-
Application of computed tomography, positron emission tomography-computed tomography, magnetic resonance imaging, endobronchial ultrasound, and mediastinoscopy in the diagnosis of mediastinal lymph node staging of non-small-cell lung cancer: A protocol for a systematic review
por: Zhang, Longguo, et al.
Publicado: (2020) -
AGT May Serve as a Prognostic Biomarker and Correlated with Immune Infiltration in Gastric Cancer
por: Wu, Fanqi, et al.
Publicado: (2022) -
The Potential Role of Small Nucleolar RNAs in Cancers – An Evidence Map
por: Wu, Fanqi, et al.
Publicado: (2022) -
Identification of potential diagnostic and therapeutic target genes for lung squamous cell carcinoma
por: Zhang, Nana, et al.
Publicado: (2019) -
m6A RNA Methylation Regulators Participate in the Malignant Progression and Have Clinical Prognostic Value in Lung Adenocarcinoma
por: Li, Fangwei, et al.
Publicado: (2020)